143
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A Probing of the Issue of Detecting IgG, IgG4 and IgA Antibodies to Laminin 332 Epitopes in Mucous Membrane Pemphigoid: A Clinical-Laboratory Experience of a Single Central European University Dermatology Department

, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 783-790 | Published online: 27 Apr 2022

References

  • Chiorean R, Danescu S, Virtic O, et al. Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid. Orphanet J Rare Dis. 2018;13(1):111. PMID: 29980216; PMCID: PMC6035451. doi:10.1186/s13023-018-0855-x
  • Schmidt E, Rashid H, Marzano AV, et al. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - part II. J Eur Acad Dermatol Venereol. 2021;35(10):1926–1948. PMID: 34309078; PMCID: PMC8518905. doi:10.1111/jdv.17395
  • Qian H, Natsuaki Y, Koga H, et al. The second study of clinical and immunological findings in anti-laminin 332-type mucous membrane pemphigoid examined at Kurume University-diagnosis criteria suggested by summary of 133 case. Front Immunol. 2021;26(12):771766. doi:10.3389/fimmu.2021.771766
  • Giurdanella F, Nijenhuis AM, Diercks GFH, Jonkman MF, Pas HH. Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases. Br J Dermatol. 2020;182(2):373–381. PMID: 31090065; PMCID: PMC7027452. doi:10.1111/bjd.18129
  • Sadler E, Lazarova Z, Sarasombath P, Yancey KB. A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer. J Dermatol Sci. 2007;47(1):1–7. doi:10.1016/j.jdermsci.2007.02.012
  • Rousselle P, Scoazec JY. Laminin 332 in cancer: when the extracellular matrix turns signals from cell Anchorage to cell movement. Semin Cancer Biol. 2020;62:149–165. doi:10.1016/j.semcancer.2019.09.026
  • Amber KT, Bloom R, Hertl M. A systematic review with pooled analysis of clinical presentation and immunodiagnostic testing in mucous membrane pemphigoid: association of anti-laminin 332 IgG with oropharyngeal involvement and the usefulness of ELISA. J Eur Acad Dermatol Venereol. 2016;30(1):72–77. doi:10.1111/jdv.13397
  • Huang C, Chen J. Laminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma. Mol Med Rep. 2021;23(1):11. PMID: 33179081; PMCID: PMC7673329. doi:10.3892/mmr.2020.11649
  • Kamaguchi M, Iwata H. The diagnosis and blistering mechanisms of mucous membrane pemphigoid. Front Immunol. 2019;10:34. doi:10.3389/fimmu.2019.00034
  • Ricotti C, Kowalczyk J, Fernandez A, Nousari CH. Mucosal “peeling” biopsy technique for the immunopathologic evaluation of desquamative gingivitis-associated mucous membrane pemphigoid. Arch Dermatol. 2008;144(11):1538. PMID: 19015440. doi:10.1001/archderm.144.11.1538
  • Carey B, Joshi S, Abdelghani A, Mee J, Andiappan M, Setterfield J. The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris. Br J Dermatol. 2020;182(3):747–753. PMID: 31021396. doi:10.1111/bjd.18032
  • Suresh L, Kumar V. Significance of IgG4 in the diagnosis of mucous membrane pemphigoid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(3):359–362. PMID: 17344074. doi:10.1016/j.tripleo.2006.12.007
  • Jałowska M, Gornowicz-Porowska J, Seraszek-Jaros A, Bowszyc-Dmochowska M, Kaczmarek E, Dmochowski M. Conceptualization and validation of an innovative direct immunofluorescence technique utilizing fluorescein conjugate against IgG + IgG4 for routinely diagnosing autoimmune bullous dermatoses. Cent Eur J Immunol. 2021;46(2):183–190. doi:10.5114/ceji.2021.107028
  • Goletz S, Giurdanella F, Holtsche MM, et al. Comparison of two diagnostic assays for anti-laminin 332 mucous membrane pemphigoid. Front Immunol. 2021;2:773720. PMID: 34899726; PMCID: PMC8657402. doi:10.3389/fimmu.2021.773720
  • Goletz S, Probst C, Komorowski L, et al. A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid. Br J Dermatol. 2019;180(1):149–156. PMID: 30216412. doi:10.1111/bjd.17202
  • Kanwar AJ, Vinay K, Koga H, Hashimoto T. Mucous membrane pemphigoid with antibodies against β3 subunit of laminin-332: first report from India. Indian J Dermatol Venereol Leprol. 2012;78(4):475–479. doi:10.4103/0378-6323.98079
  • Gasparini G, Cozzani E, Di Zenzo G, et al. Anti-laminin 332 antibody detection using biochip immunofluorescence microscopy in a real-life cohort of Italian patients with mucous membrane pemphigoid. Eur J Dermatol. 2021;26. PMID: 34463277. doi:10.1684/ejd.2021.4104
  • Bernard P, Antonicelli F, Bedane C, et al. Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol. 2013;149(5):533–540. doi:10.1001/jamadermatol.2013.1434
  • Koneczny I, Yilmaz V, Lazaridis K, et al. Common denominators in the immunobiology of igg4 autoimmune diseases: what do glomerulonephritis, pemphigus vulgaris, myasthenia gravis, thrombotic thrombocytopenic purpura and autoimmune encephalitis have in common? Front Immunol. 2021;11:605214. PMID: 33584677; PMCID: PMC7878376. doi:10.3389/fimmu.2020.605214
  • van Beek N, Kridin K, Bühler E, et al. Evaluation of site- and autoantigen-specific characteristics of mucous membrane pemphigoid. JAMA Dermatol. 2022;158(1):84–89. doi:10.1001/jamadermatol.2021.4773
  • La Placa M, Balestri R, Tartari F, et al. Mucous membrane pemphigoid-associated malignancies: case series and a brief overview of the literature. Dermatol Pract Concept. 2019;9(2):119–125. PMID: 31106014; PMCID: PMC6502303. doi:10.5826/dpc.0902a07
  • Jałowska M, Gornowicz-Porowska J, Dmochowski M. Mucous membrane pemphigoid as a paraneoplastic symptom. Derm Dypl. 2020;11(4):32–35.
  • Gornowicz-Porowska J, Seraszek-Jaros A, Bowszyc-Dmochowska M, et al. Accuracy of molecular diagnostics in pemphigus and bullous pemphigoid: comparison of commercial and modified mosaic indirect immunofluorescence tests as well as enzyme-linked immunosorbent assays. Postepy Dermatol Alergol. 2017;34(1):21–27. PMID: 28261028; PMCID: PMC5329104. doi:10.5114/ada.2017.65617
  • Dmochowski M, Hashimoto T, Bhogal BS, Black MM, Zone JJ, Nishikawa T. Immunoblotting studies of linear IgA disease. J Dermatol Sci. 1993;6(3):194–200. PMID: 8136317. doi:10.1016/0923-1811(93)90038-q
  • Zone JJ, Taylor TB, Meyer LJ, Petersen MJ. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol. 1998;110(3):207–210. PMID: 9506436. doi:10.1046/j.1523-1747.1998.00129.x
  • Hayashi I, Shinkuma S, Shimizu S, et al. Mucous membrane pemphigoid with generalized blisters: igA and IgG autoantibodies target both laminin-332 and type XVII collagen. Br J Dermatol. 2012;166(5):1116–1120. PMID: 22182184. doi:10.1111/j.1365-2133.2011.10776.x
  • Holtsche MM, Goletz S, von Georg A, et al. Serologic characterization of anti-p200 pemphigoid: epitope spreading as a common phenomenon. J Am Acad Dermatol. 2020;84(4):1155–1157. doi:10.1016/j.jaad.2020.07.076
  • Natsuga K, Nishie W, Shinkuma S, et al. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid. Br J Dermatol. 2010;162(3):513–517. PMID: 19751242. doi:10.1111/j.1365-2133.2009.09508.x